Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 31

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Multimodal imaging risk factors predictive of small choroidal melanocytic lesion growth to melanoma: An educational study and pictorial guide

Trisha Yuuno Castillo Pecoraro; Robert Churchill; Andrea A. Tooley; Odette Houghton; Arman Mashayekhi; Lauren A Dalvin

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):897.

ARVO Annual Meeting Abstract July 2019

Intravitreal melphalan for vitreoretinal lymphoma

Li-Anne S Lim; Lauren A Dalvin; David Ancona-Lezama; Michael Chang; Arman Mashayekhi; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2778.

ARVO Annual Meeting Abstract July 2019

Survival Times in Patients with Vitreoretinal Lymphoma. Analysis of 95 Patients at a Single Ocular Oncology Center.

Lauren A Dalvin; Li-Anne S Lim; David Ancona-Lezama; Mehdi Mazloumi; Michael Chang; Arman Mashayekhi; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3543.

ARVO Annual Meeting Abstract July 2019

Prophylactic Intravitreal Bevacizumab after Plaque Radiotherapy for Uveal Melanoma: Analysis of 1311 Eyes of 1310 Patients by Age

Michael Chang; Lauren A Dalvin; Li-Anne S Lim; Mehdi Mazloumi; Antonio Yaghy; Arman Mashayekhi; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):721.

ARVO Annual Meeting Abstract June 2017

Cytogenetic evaluation of 26 patients with documented transformation of iris nevus into iris melanoma

Maria Pefkianaki; Archana Srinivasan; Arman Mashayekhi; Jerry A Shields; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4420.

ARVO Annual Meeting Abstract September 2016

High dose (2.5 mg) intravitreal bevacizumab as rescue therapy for persistent post-radiation cystoid macular edema

M. Ali Khan; Arman Mashayekhi; Kyle Ferguson; Jerry A Shields; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4099.

ARVO Annual Meeting Abstract September 2016

Cytogenetic evaluation of 32 patients with uveal melanoma photographically documented to originate from choroidal nevus

Maria Pefkianaki; Arman Mashayekhi; Enzo Fulco; Vanessa Fulco; Jerry A Shields; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5890.

ARVO Annual Meeting Abstract June 2015

Intravitreal Aflibercept as Rescue Therapy for Post-Radiation Cystoid Macular Edema

Mohammed Ali Khan; Arman Mashayekhi; Jerry A Shields; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1292.

ARVO Annual Meeting Abstract June 2015

Photodynamic Therapy for Symptomatic Choroidal Nevi in 23 Cases

Wasim A Samara; Chloe TL Khoo; Renelle Pointdujour Lim; George Magrath; Arman Mashayekhi; Jerry A Shields; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3441.

ARVO Annual Meeting Abstract June 2015

Fine-Needle Aspiration Biopsy of Solitary Amelanotic Choroidal Tumors in 200 Cases

Chloe TL Khoo; Wasim A Samara; Adel Al Set; Arman Mashayekhi; Emil A Say; Jerry A Shields; Carol L Shields

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5327.

ARVO Annual Meeting Abstract March 2012

Management Of Uveal Melanomas With Extraocular Extension: Enucleation Versus Plaque Radiotherapy

Ahmet Sarici; Arman Mashayekhi; Carol L. Shields; Swati Kaliki; Saad AlDahmash; Jerry A. Shields

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3407.

ARVO Annual Meeting Abstract April 2011

Slow Increase In Thickness Of Presumed Choroidal Melanomas And Chromosome 3 Status

Emil Anthony T. Say; Arman Mashayekhi; Carol L. Shields; Jerry A. Shields

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1434.

ARVO Annual Meeting Abstract April 2011

Long-term Outcome of Cavitary Retinoblastoma in 22 Patients

juan c. iturralde; Emil A. Say; Arman Mashayekhi; Sara Lally; Carol L. Shields

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1597.

ARVO Annual Meeting Abstract April 2010

Conjunctival Melanoma: Origin From Primary Acquired Melanosis and Nevus Shows Less Risk for Melanoma-Related Death Than Origin de Novo

I. Belinsky; C. Shields; J. Markowitz; H. Schwartzstein; N. George; S. Lally; A. Mashayekhi; J. Shields

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):849.

ARVO Annual Meeting Abstract April 2010

Multi-Tissue Ocular Melanocytosis: Risk of Development of Uveal Melanoma

A. Mashayekhi; C. Park; C. L. Shields; J. A. Shields

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):853.

ARVO Annual Meeting Abstract April 2010

Retinal Pigment Epithelial Trough: A Sign of Senescence and Stability of Choroidal Nevi

J. A. Shields; A. Mashayekhi; S. Siu; C. L. Shields

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):860.

ARVO Annual Meeting Abstract April 2010

Plaque Radiotherapy for Management of Small Choroidal Melanoma: A Series of 1251 Cases

E. T. Say; C. L. Shields; B. Kligman; K. Turaka; A. Mashayekhi; M. Alterman; J. A. Shields

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5141.

ARVO Annual Meeting Abstract April 2010

Outcomes of Plaque Radiotherapy for Small (< 3 mm Thickness) Choroidal Melanoma in the Macular Region

L. Malaviya; C. Shields; B. Kligman; K. Turaka; A. Mashayekhi; J. Shields

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5144.

ARVO Annual Meeting Abstract April 2009

Slow Growth of Choroidal Nevi: Long-Term Follow-Up of 278 Patients

A. Mashayekhi; C. L. Shields; S. Siu; J. A. Shields

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5702.

ARVO Annual Meeting Abstract April 2009

Clinical Features and Natural Course of Giant Choroidal Nevus in 322 Cases

H. K. Li; J. Randolph; A. Mashayekhi; C. L. Shields; T. Bailey; J. Burnbaum; J. A. Shields

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5703.

1 2

Next 20 Results »

Advertisement